Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Bexley Dermatology Research - Probity - PPDS

Bexley, Ohio, United StatesNot linked to an institution yet

1running trial
2closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

No trial has been confirmed here yet.

Running trials

Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
NCT06550076· Phase 3· Source

Researchers

No researcher is linked here yet.

Closed trials

Completed
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
NCT06973291· Phase 3· Source
Completed
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment
NCT06088043· Phase 3· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Bexley Dermatology Research - Probity - PPDS: trial site – Frontlight Research